||Actinium Pharmaceuticals is focused on the research, development and commercialization of the alpha emitting isotopes bismuth 213 (Bi-213) and actinium 225 (Ac-225) for fighting cancer and other cellular diseases.
philosophy behind Bio Balance is that accurate
descriptions of drug-receptor interactions will
lead to the development of better pharmaceuticals.
Bio Balance is devoted to a biophysical description
of the initial receptor response.
Squibb is a leading diversified worldwide health
and personal care company whose principal businesses
are medicines, beauty care, nutritionals, and
||Cambridge Biomedical is is focused on providing custom assay development, qualification and validation services.
||Cynvec is focused on the development of the company's proprietary oncolytic sindbis viral vector for the treatment of cancer that overexpress the laminin receptor.
||Delcath Systems is focused on the development and commercialization of a cancer therapy that allows isolation and administration high doses of chemotherapeutic agents to a diseased organ or a region of the body to increase efficacy and decrease side effects.
||Enumeral Biomedical is focused on the discovery of native human monoclonal antibodies using a proprietary high-density bio-chip microarray.
Laboratories is invovled in the discovery, development,
and comercialization of drugs primarily in the areas
of central nervous system, cardiovascular, and respiratory
Laboratories, Inc. is a world leader in providing
diagnostic, detection, and information products
to the animal health industry as well as quality
assurance products and services to the dairy and
is a biopharmaceutical company dedicated to the
development of novel treatments for cancer and
||Intra-Cellular Therapies is focused on the research and development of drugs for the treatment of diseases and disorders of the Central Nervous System (CNS).
||Intercept Pharmaceuticals is focused on the development and commercialization of treatments for patients with chronic liver diseases.
||Keryx Biopharmaceuticals is focused on the acquisition, development, and commercialization of products for the treatment of patients with cancer and renal disease.
||Mesoblast is focused on the research, development, and commercialization of stem cell technologies for the treatment of patients with various diseases.
||Myrexis is focused on research and development of small molecules for the treatment of patients with cancer.
||NexGenix Pharmaceuticals is focused on the discovery and development of therapeutics for cancer and nervous system disorders.
||Novartis engages in the research, development, and commercialization of a range of healthcare products.
||Ohr Pharmaceutical is focused on the research and development of therapeutic drugs for for the treatment of a variety of conditions.
|| Pfizer Inc. is involved in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide.
|| Phosplatin Therapeutics is focused on the research and development of small molecule cancer therapeutics.
|Progenitor Cell Therapy
||Progenitor Cell Therapy is focused on providing cGMP-compliant cell manufacturing and consulting services.
||Promosome is focused on the development and commercialization of a technology which enhances protein synthesis for biotherapeutics.
||SIGA designs and develops novel countermeasures to prevent and treat serious infectious diseases, with an emphasis on biological warfare defense.
||Synergy Pharmaceuticals is focused on the discovery and development of drugs to treat gastrointestinal (GI) conditions and diseases.
||Tactical Therapeutics is focused on the research and development of small molecule therapeutics for treatment of cancer and other diseases.
||Tonix Pharmaceuticals is focused on the research and development of treatments for patients with fibromyalgia or post-traumatic stress disorder.
||Ventrus Biosciences is focused on the development of drugs for treatment of patients with gastrointestinal disorders.
||Ziopharm Oncology is focused on the research and development of small molecule drugs for cancer.